Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis.

Gillissen A, Wittig T, Ehmen M, Krezdorn HG, de Mey C.

Drug Res (Stuttg). 2013 Jan;63(1):19-27. doi: 10.1055/s-0032-1331182. Epub 2013 Jan 8.

PMID:
23447044
2.
4.
6.

[Chronic obstructive bronchitis. Effect of Gelomyrtol forte in a placebo-controlled double-blind study].

Ulmer WT, Schött D.

Fortschr Med. 1991 Sep 20;109(27):547-50. German.

PMID:
1794831
8.
9.
11.
12.
13.

Is Myrtol® Standardized a New Alternative toward Antibiotics?

Paparoupa M, Gillissen A.

Pharmacogn Rev. 2016 Jul-Dec;10(20):143-146. doi: 10.4103/0973-7847.194045. Review.

14.

EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial.

Matthys H, Funk P.

Planta Med. 2008 May;74(6):686-92. doi: 10.1055/s-2008-1074519. Epub 2008 Apr 30.

PMID:
18449849
15.
16.

[Myrtol standardized in the treatment of acute and chronic respiratory infections in children. A multicenter post-marketing surveillance study].

Sengespeik HC, Zimmermann T, Peiske C, de Mey C.

Arzneimittelforschung. 1998 Oct;48(10):990-4. German.

PMID:
9825116
17.

Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study.

Melbye H, Aasebø U, Straume B.

Fam Pract. 1991 Sep;8(3):216-22.

PMID:
1959720
18.

Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept.

Schutz A, Gund HJ, Pschorn U, Aicher B, Peil H, Müller A, de Mey C, Gillissen A.

Arzneimittelforschung. 2002;52(3):194-9.

PMID:
11963647

Supplemental Content

Support Center